***TASK*** the task is to summarize an input biomedical literature in six sentences 
    ***INPUT*** the input is a biomedical literature 
    ***OUTPUT*** the output is the summary of an input biomedical literature in six sentences 
    ***DOCUMENTATION*** 
    ***EXAMPLES*** 
    Input: Introduction Inadequate initial treatment and delayed hemodynamic stabilization ( HDS ) may be associated with increased risk of death in severe sepsis patients . Methods In order to compare the hemodynamic efficacy and safety of 6 % HES 130/0.4 and NaCl 0.9 % for HDS in patients with severe sepsis , we design ed a prospect i ve , multicenter , active-controlled , double-blind , r and omized study in intensive care units . Results 174 out of 196 patients reached HDS ( 88 and 86 patients for HES and NaCl , respectively ) . Significantly less HES was used to reach HDS vs. NaCl ( 1,379 ±886 ml in the HES group and 1,709 ±1,164 ml in the NaCl group ( mean difference = -331± 1,033 , 95 % CI -640 to -21 , P = 0.0185 ) . Time to reach HDS was 11.8 10.1 hours vs. 14.3 ±11.1 hours for HES and NaCl , respectively . Total quantity of study drug infused over four consecutive days , ICU and hospital LOS , and area under the curve of SOFA score were comparable . Acute renal failure occurred in 24 ( 24.5 % ) and 19 ( 20 % ) patients for HES and NaCl , respectively ( P = 0.454 ) . There was no difference between AKIN and RIFLE criteria among groups and no difference in mortality , coagulation , or pruritus up to 90 days after treatment initiation . Conclusion Significantly less volume was required to achieve HDS for HES vs. NaCl in the initial phase of fluid resuscitation in severe sepsis patients without any difference for adverse events in both groups . Clinical Trials.gov To assess the effects of crystalloid and colloid resuscitation on hemodynamic response and on lung water  following thermal injury , 79 patients were assigned r and omly to receive lactated Ringer 's solution or 2.5 % albumin-lactated Ringer 's solution . Crystalloid-treated patients required more fluid for successful resuscitation than did those receiving colloid solutions ( 3.81 vs. 2.98 ml/kg body weight/% body surface burn , p < 0.01 ) . In study phase 1 ( 29 patients ) , cardiac index and myocardial contractility ( ejection fraction ' and mean rate of internal fiber shortening , Vcf ) were determined by echocardiography during the first 48 hours postburn . Cardiac index was lower in the 12-to 24-hour postburn interval in the crystalloid group , but this difference between treatment groups had disappeared by 48 hours postburn . Ejection fractions were normal throughout the entire study , while Vcf was supranormal ( p < 0.01 vs. normals ) and equal in the two resuscitation groups . In study phase 2 ( SO patients ) , extravascular lung water and cardiac index were measured by a st and ard rebreathing technique at least daily for the first postburn week . Lung water remained unchanged in the crystalloid-treated patients ( p > 0.10 ) , but progressively increased in the colloid-treated patients over the seven day study ( p < 0.0001 ) . The measured lung water in each treatment group was significantly different from one another ( p < 0.001 ) . Cardiac index increased progressively and identically in both treatment groups over the study period ( p < 0.01 ) . These data refute the existence of myocardial depression during postburn resuscitation and document hypercontractile left ventricular performance . The addition of colloid to crystalloid resuscitation fluids produces no long lasting benefit on total body blood flow , and promotes accumulation of lung water when edema fluid is being reabsorbed from the burn wound Background The use of hypertonic crystalloid solutions , including sodium chloride and bicarbonate , for treating severe sepsis has been much debated in previous investigations . We have investigated the effects of three crystalloid solutions on fluid resuscitation in severe sepsis patients with hypotension . Methods Ninety-four severe sepsis patients with hypotension were r and omly assigned to three groups . The patients received the following injections within 15 min at initial treatment : Ns group ( n = 32 ) , 5 ml/kg normal saline ; Hs group ( n = 30 ) , with 5 ml/kg 3.5 % sodium chloride ; and Sb group ( n = 32 ) , 5 ml/kg 5 % sodium bicarbonate .  Cardiac output ( CO ) , systolic blood pressure , mean arterial pressure ( MAP ) , body temperature , heart rate , respiratory rate and blood gases were measured . Results There were no differences among the three groups in CO , MAP , heart rate or respiratory rate during the 120 min trial or the 8 hour follow-up , and no significant differences in observed mortality rate after 28 days . However , improvement of MAP and CO started earlier in the Sb group than in the Ns and Hs groups . Sodium bicarbonate increased the base excess but did not alter blood pH , lactic acid or [HCO3]- values ; and neither 3.5 % hypertonic saline nor 5 % sodium bicarbonate altered the Na+ , K+ , Ca2 + or Cl- levels . Conclusion All three crystalloid solutions may be used for initial volume loading in severe sepsis , and sodium bicarbonate confers a limited benefit on humans with severe sepsis . Trial registration IS RCT N36748319 Abstract . The objective of this study was to compare the cardiac and hemodynamic responses to a rapid infusion of 1000 ml of modified fluid gelatin ( group A ) or 1000 ml of lactated Ringer 's solution ( group B ) in emergency room patients suffering from shock . This prospect i ve , r and omized , open , noncrossover study was performed at a medical center university hospital in a surgical resuscitation room in the emergency department . The subjects were 34 patients with either hypovolemic or neurogenic shock who were admitted to the emergency room . A resuscitation protocol according to Advanced Trauma Life Support ( ATLS ) with an additional central venous line or Swan-Ganz catheters for hemodynamic monitoring was used . Physical parameters and hemodynamic variables were measured at baseline and 15 minutes , 30 minutes , and 1 hour after the infusion of each fluid . In both groups the mean arterial blood pressure ( MAP ) , systolic and diastolic pressure , central venous pressure ( CVP ) , and pulmonary artery occlusion pressure ( PAOP ) increased significantly . The CVP and PAOP increased significantly more in the modified fluid gelatin resuscitation group . In patients with traumatic or neurogenic shock due to acute volume deficiency , there was significantly better hemodynamic improvement , judged by CVP and PAOP measurements using the modified fluid gelatin for volume replacement than with lactated Ringer 's solution during the first hour of resuscitation BACKGROUND Both balanced crystalloids and saline are used for intravenous fluid administration in critically ill adults , but it is not known which results in better clinical outcomes . METHODS In a pragmatic , cluster‐r and omized , multiple‐crossover trial conducted in five intensive care units at an academic center , we assigned 15,802 adults to receive saline ( 0.9 % sodium chloride ) or balanced crystalloids ( lactated Ringer 's solution or Plasma‐Lyte A ) according to the r and omization of the unit to which they were admitted . The primary outcome was a major adverse kidney event within 30 days — a composite of death from any cause , new renal‐replacement therapy , or persistent renal dysfunction ( defined as an elevation of the creatinine level to ≥200 % of baseline ) — all censored at hospital discharge or 30 days , whichever occurred first . RESULTS Among the 7942 patients in the balanced‐crystalloids group , 1139 ( 14.3 % ) had a major adverse kidney event , as compared with 1211 of 7860 patients ( 15.4 % ) in the saline group ( marginal odds ratio , 0.91 ; 95 % confidence interval [ CI ] , 0.84 to 0.99 ; conditional odds ratio , 0.90 ; 95 % CI , 0.82 to 0.99 ; P=0.04 ) . In‐hospital mortality at 30 days was 10.3 % in the balanced‐crystalloids group and 11.1 % in the saline group ( P=0.06 ) . The incidence of new renal‐replacement therapy was 2.5 % and 2.9 % , respectively ( P=0.08 ) , and the incidence of persistent renal dysfunction was 6.4 % and 6.6 % , respectively ( P=0.60 ) . CONCLUSIONS Among critically ill adults , the use of balanced crystalloids for intravenous fluid administration result ed in a lower rate of the composite outcome of death from any cause , new renal‐replacement therapy , or persistent renal dysfunction than the use of saline . ( Funded by the V and erbilt Institute for Clinical and Translational Research and others ; SMART‐MED and SMART‐SURG Clinical Trials.gov numbers , NCT02444988 and NCT02547779 . BACKGROUND Normal saline ( NS ) is the most commonly used crystalloid solution worldwide but contains an excess of chloride and may cause metabolic acidosis and hyperchloraemia . Such abnormalities may be attenuated by the use of a balanced solution such as Plasma-Lyte 148 ( PL-148 ) . OBJECTIVE To assess the feasibility , safety and biochemical and physiological effects of resuscitation with NS versus PL-148 in critically ill patients . DESIGN , SETTING AND PARTICIPANTS An exploratory , multicentre , doubleblind , r and omised controlled trial involving patients aged ≥ 18 years who were prescribed crystalloid fluid resuscitation by the treating clinician between 16 July and 22 October 2015 , in three multidisciplinary intensive care units in Melbourne , Victoria , Australia . METHODS R and om allocation of NS or PL-148 was concealed , and all fluids were delivered in indistinguishable bags . INTERVENTION NS or PL-148 was administered for all fluid resuscitation and for all subsequent crystalloid fluid therapy until Day 4 of ICU admission . The treating intensivist determined the rate and frequency of fluid administration . MAIN OUTCOME MEASURES Primary outcome was daily base excess ( BE ) . Relevant secondary outcomes included the incidence of acute kidney injury ( AKI ) , change in serum creatinine and serum chloride levels , and mortality . RESULTS Seventy patients were recruited , with 34 in the NS group and 33 in the PL-148 group available for analysis . Baseline characteristics of study patients were well balanced ; the mean ages were 64 and 62 years , respectively , and nearly two-thirds of the patients in each group were men .  The median Acute Physiology and Chronic Health Evaluation III scores were 64 for the NS group ( interquartile range [ IQR ] , 48 - 73 ) and 55 for the PL-148 group ( IQR , 44 - 81 ) . After treatment , there was no significant difference in the worst ( most negative ) median BE between the NS and PL-148 groups ( -4 mEq/L [ IQR , -7 to -2 mEq/L ] v -3 mEq/L [ IQR , -7 to 2 mEq/L ] ; P = 0.42 ) . Chloride levels were significantly higher with NS therapy ( median , 111 mmol/L [ IQR , 108 - 116 mmol/L ] v 108 mmol/L [ IQR , 106 - 110 mmol/L ] ; P = 0.01 ) . There was no significant difference in the incidence of AKI ( P = 0.48 ) , peak creatinine levels ( P = 0.92 ) or ICU or hospital mortality between the two groups . CONCLUSIONS In our exploratory , double-blind , r and omised controlled trial , when compared with NS , PL-148 did not significantly increase BE values in critically ill patients requiring fluid resuscitation , but decreased peak chloride concentrations Introduction We sought to investigate whether the use of balanced solutions reduces the incidence of hyperchloraemic acidosis without increasing the risk for intracranial hypertension in patients with severe brain injury . Methods We conducted a single-centre , two-arm , r and omised , double-blind , pilot controlled trial in Nantes , France . Patients with severe traumatic brain injury ( Glasgow Coma Scale score ≤8 ) or subarachnoid haemorrhage ( World Federation of Neurosurgical Society grade III or higher ) who were mechanically ventilated were r and omised within the first 12 hours after brain injury to receive either isotonic balanced solutions ( crystalloid and hydroxyethyl starch ; balanced group ) or isotonic sodium chloride solutions ( crystalloid and hydroxyethyl starch ; saline group ) for 48 hours . The primary endpoint was the occurrence of hyperchloraemic metabolic acidosis within 48 hours . Results Forty-two patients were included , of whom one patient in each group was excluded ( one consent withdrawn and one use of forbidden therapy ) . Nineteen patients ( 95 % ) in the saline group and thirteen ( 65 % ) in the balanced group presented with hyperchloraemic acidosis within the first 48 hours ( hazard ratio = 0.28 , 95 % confidence interval 
    Output:
    
Conclusion BCs , especially the Plasma-Lyte , are presumably the best choice for most critically ill patients who need fluid resuscitation .
Meanwhile , the use of H-HES was associated with an increased incidence of AKI and risk of receiving RRT .